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pass: An Updated, Systematic Review of Early Outcomes
Fareed K.R., Rothwell P.M., Mehta Z., Naylor A.R. Eur J Vasc Endovasc
Surg 2009;xx:xx-xx.
Objectives: To update our previous systematic review of outcomes
following synchronous carotid endarterectomy (CEA) and off-pump coro-
nary artery bypass grafting (OFF-CABG).
Design: A systematic review of operative risks reported in published
studies of synchronous CEA plus OFF-CABG procedures.
Results: We identified 12 eligible studies, including data on 324
synchronous CEA plus OFF-CABG procedures. Operative mortality was
1.5% (95% confidence interval (CI): 0.3–2.8), the risk of death or ipsilateral
stroke was 1.6% (0.4–2.8%), risk of death or any stroke was 2.2% (95% CI:
0.7–3.7) and the risk of death, stroke ormyocardial infarction was 3.6% (95%
CI: 1.6–5.5).
Conclusions: Limited published data on 324 patients suggest that
early outcomes after synchronous CEA plus OFFCABG are better than
those following staged or synchronous CEA plus CABG where the cardiac
procedure was performed on-pump. This may, however, be attributed to
publication bias, case selection or the fact that the aorta was not manipulated
or cannulated, rather than CEA being primarily responsible for the lower
stroke risk. Colleagues with unpublished experience of CEA plus OFF-
CABG are encouraged to submit their data to further inform the debate.
A Systematic Review and Meta-analysis of 30-Day Outcomes Follow-
ing Staged Carotid Artery Stenting and Coronary Bypass
Naylor A. Ross, Mehta Z., Rothwell P.M. Eur J Vasc Endovasc Surg
2009;xx:xx-xx.
Objectives: To determine the overall operative risk of cardiovascular
events in patients with combined cardiac and carotid artery disease under-
going staged carotid artery stenting (CAS) and coronary artery bypass
grafting (CABG).
Design: Systematic review of operative risks reported in all published
studies of CAS plus CABG procedures.
Results: Eleven eligible, published studies were identified which re-
ported data on 760 CAS plus CABG procedures. The majority of patients
(87%) were neurologically asymptomatic and 82% had unilateral carotid
stenoses. Overall mortality was 5.5% (95% confidence interval, CI: 3.4–7.6),
the risk of suffering an ipsilateral stroke was 3.3% (95% CI: 1.6–5.1) and the
risk of suffering ‘any’ stroke was 4.2% (95% CI: 2.4–6.1), while the 30-day
risk of myocardial infarction (MI) was only 1.8% (95% CI: 0.5–3.0). How-
ever, the 30-day death and ipsilateral stroke rate was 7.5% (95% CI: 4.5–
10.5) and the 30-day risk of death and any stroke was 9.1% (95% CI:
6.1–12.0), while the 30-day of death/stroke/MI was 9.4% (7.0–11.8).
Cumulative risks in studies where patients underwent CABG within 48 h of
CAS were not higher than in comparable studies where CABG was delayed
by more than 2 weeks.
Conclusions: In a cohort of predominantly asymptomatic patients
with unilateral carotid disease, the 30-day risk of death/any stroke was 9.1%.
These data are comparable to previous systematic reviews evaluating the
roles of staged and synchronous carotid endarterectomy (CEA) plus CABG,
and suggest that staged CAS plus CABG is an attractive and less invasive
alternative to CEA plus CABG. However, it remains questionable whether
the observed 9% risks can be justified in any asymptomatic patient with
unilateral carotid disease.
Serum Myoglobin and Renal Morbidity and Mortality following Tho-
racic and Thoraco-Abdominal Aortic Repair: Does Rhabdomyolysis
Play a Role?
Miller C.C. III, Villa M.A., Sutton J., Lau D., Keyhani K., Estrera A.L.,
Azizzadeh A., Coogan S.M., Safi H.J. Eur J Vasc Endovasc Surg 2009;xx:
xx-xx.
Objectives: The intractability of renal dysfunction following thoracic
and thoraco-abdominal aortic repair leads us to believe that the accepted
mechanisms of renal injury – ischaemia and embolism – are incompletely
explanatory. We studied postoperative myoglobinaemia and renal dysfunc-
tion following aortic surgery.
1086Methods: Between September 2006 and February 2008, we studied
serum myoglobin in 109 patients requiring thoracic/thoraco-abdominal
repair for three postoperative days. Forty-two of the 109 (38%) patients were
female. The median age was 67 years (range 23–84 years). As we have
focussed more attention on renal function, our independent renal consult-
ants have dialysed more aggressively. We divided dialysis into: (1) creatinine
indication, (2) non-creatinine indication and (3) no dialysis.
Results: Thirteen of the 109 (12%) patients met creatinine indication
for dialysis (4 mg dl1) and an additional 28 (26%) were dialysed for other
reasons. Overall mortality was 12 out of 109 (11%) cases: 11 out of 41 (27%)
in dialysed patients and one out of 68 (1.5%) in non-dialysed patients.
Mortality did not differ between the indications for dialysis. Predictors of
mortality were baseline glomerular filtration rate (GFR), postoperative
myoglobin and dialysis. The only predictor of dialysis was postoperative
myoglobin.
Conclusion: A strong relationship between postoperative serum myo-
globin and renal failure suggests a rhabdomyolysis-like contributing aetiol-
ogy following thoraco-abdominal aortic repair. We postulate a novel mech-
anism of renal injury for which mitigation strategies should be developed.
Is Endovascular Repair of Mycotic Aortic Aneurysms a Durable Treat-
ment Option?
Clough R.E., Black S.A., Lyons O.T., Zayed H.A., Bell R.E., Carrell T.,
WalthamM., Sabharwal T., Taylor P.R. Eur J Vasc Endovasc Surg 2009;xx:
xx-xx.
Objective: Endovascular repair for degenerative aortic aneurysms is
well established, but its role in those with infective pathology remains
controversial. This study aims to assess the durability of endovascular repair
with a review of our midterm results.
Method: A retrospective analysis of a prospectively maintained endo-
vascular database (1998–2008) was conducted, which identified 673 con-
secutive patients with aortic aneurysms.
Results: Nineteen patients (2.8%) were identified with infected aortic
aneurysms, in which there were a total of 23 separate aneurysms (16 thoracic
and seven abdominal). Six patients (32%) presented with rupture. Eleven
patients (58%) had received antibiotics preoperatively for a median duration
of 11 days (1–54 days). Fifteen of the 19 (79%) had positive blood cultures,
with Staphylococcus aureus being the most common organism.
All 19 patients underwent endovascular repair. There were three Type
I endoleaks (one requiring conversion to open repair) and two Type II
endoleaks. One patient developed transient paraplegia, resolved by cerebro-
vascular fluid (CSF) drainage, and one patient had a stroke.
The 30-day mortality was 11%, and survival at median follow-up of 20
months (0–83 months) was 73%. All eight deaths in the series were related
to aneurysm.
Conclusion: Endovascular treatment of infective aortic pathology
provides an early survival benefit; however, concerns over on-going graft
infection remain.
Is There a Benefit of Frequent CT Follow-up After EVAR?
Dias N.V., Riva L., Ivancev K., Resch T., Sonesson B., MalinaM. Eur J Vasc
Endovasc Surg 2009;xx:xx-xx.
Objective: Imaging follow-up (FU) after endovascular aneurysm repair
(EVAR) is usually performed by periodic contrast-enhanced computed
tomography (CT) scans. This study aims to evaluate the effectiveness of
CT-FU after EVAR.
Methods: In this study, 279 of 304 consecutive patients (261 male,
aged 74 years (interquartile range (IQR): 70–79 years) with a median
abdominal aortic aneurysm (AAA) diameter of 58 mm (IQR: 53–67 mm))
underwent at least one of the yearly CT scans and plain abdominal films after
EVAR. All patients received Zenith stent-grafts for non-ruptured AAAs at a
single institution. Patients were considered asymptomatic when a re-inter-
vention was done solely due to an imaging FU finding. The data were
prospectively entered in a computer database and retrospectively analysed.
Results: As a follow-up, 1167 CT scans were performed at a median of
54 months (IQR: 34–74 months) after EVAR. Twenty-seven patients
exhibited postoperative AAA expansion (a 5-year expansion-free rate of
88  2%), and 57 patients underwent 78 postoperative re-interventions
